EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Leveraging Artificial Intelligence for the Diagnosis of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: Opportunities, Challenges, and Future Perspectives

Samiksha Jain iD, Avneet Kaur, Abdul Qadeer iD, Victor Ghosh iD, Shivani Thota, Mallareddy Banala iD, Jieun Lee, Gayathri Yerrapragada, Poonguzhali Elangovan, Mohammed Naveed Shariff iD, Thangeswaran Natarajan iD, Jayarajasekaran Janarthanan und 9 weitere

Advances in Respiratory Medicine · 2025

DOI: 10.3390/arm93050047 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Respiratory Medicine, 2025. Verfasst von Samiksha Jain und 20 weiteren Autor:innen. Beteiligte Einrichtung: Guntur Medical College, Guntur 522004, Andhra Pradesh, India. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Artificial Intelligence, Pulmonary Arterial Hypertension, Hypertension, Pulmonary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) is a life-threatening vascular complication of SSc, marked by high morbidity and mortality. Early diagnosis remains a major challenge due to nonspecific symptoms and the limitations of conventional tools such as echocardiography (ECHO), pulmonary function tests (PFTs), and serum biomarkers. This review evaluates the emerging role of artificial intelligence (AI), particularly machine learning (ML) and deep learning (DL), in improving the diagnostic landscape of SSc-PAH. A comprehensive literature search was conducted across PubMed, Scopus, IEEE Xplore, Embase and Google Scholar to identify studies involving AI applications in SSc, pulmonary arterial hypertension (PAH), and their intersection. Evidence indicates that AI models can assist interpretation across modalities, including heart sounds, ECGs, chest X-rays (CXRs), ECHOs, CT pulmonary angiography (CTPA), and omics-based biomarkers. While several models show encouraging diagnostic performance, their accuracy varies by dataset and modality, and most require external validation against right heart catheterization (RHC)-confirmed cohorts. Integrating multimodal data through AI frameworks may enhance early recognition and individualized risk stratification; however, these tools remain exploratory. Future work should emphasize harmonized hemodynamic definitions, transparent validation protocols, and SSc-specific datasets to ensure clinical applicability and reproducibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicArtificial IntelligencePulmonary Arterial HypertensionHypertension, PulmonaryHumansDeep Learning

Stichwörter der Autor:innen

artificial intelligencedeep learningmachine learningpulmonary arterial hypertensionsystemic sclerosis

Autor:innen und Institutionen

  • Guntur Medical College, Guntur 522004, Andhra Pradesh, India.
  • Department of Internal Medicine, MedStar Union Memorial Hospital, Baltimore, MD 21218, USA.
  • Department of Cardiovascular Medicine, The University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Andhra Medical College, Visakhapatnam 530002, Andhra Pradesh, India.
  • Kamineni Institute of Technology and Sciences, Hyderabad 508254, Telangana, India.
  • Department of Radiology, University of Miami/Jackson Health System, Miami, FL 33136, USA.

ORCID-Profile: Samiksha Jain, Abdul Qadeer, Victor Ghosh, Mallareddy Banala, Mohammed Naveed Shariff, Thangeswaran Natarajan, Vivek N Iyer, Scott A Helgeson, Shivaram P Arunachalam

Zitieren

APA

Jain, S., Kaur, A., Qadeer, A., Ghosh, V., Thota, S., Banala, M., Lee, J., Yerrapragada, G., Elangovan, P., Shariff, M. N., Natarajan, T., Janarthanan, J., Jayapradhaban Kala, J., Richard, S., Vommi, S. P., Karuppiah, S. S., Muthyala, A., Iyer, V. N., Helgeson, S. A., …, & Arunachalam, S. P. (2025). Leveraging Artificial Intelligence for the Diagnosis of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: Opportunities, Challenges, and Future Perspectives. Advances in Respiratory Medicine. https://doi.org/10.3390/arm93050047

Vancouver

Jain S, Kaur A, Qadeer A, Ghosh V, Thota S, Banala M, et al. Leveraging Artificial Intelligence for the Diagnosis of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: Opportunities, Challenges, and Future Perspectives. Advances in Respiratory Medicine. 2025. doi:10.3390/arm93050047

BibTeX
@article{Jain2025,
  author = {Jain, Samiksha and Kaur, Avneet and Qadeer, Abdul and Ghosh, Victor and Thota, Shivani and Banala, Mallareddy and Lee, Jieun and Yerrapragada, Gayathri and Elangovan, Poonguzhali and Shariff, Mohammed Naveed and Natarajan, Thangeswaran and Janarthanan, Jayarajasekaran and Jayapradhaban Kala, Jayavinamika and Richard, Samuel and Vommi, Saai Poornima and Karuppiah, Shiva Sankari and Muthyala, Anjani and Iyer, Vivek N and Helgeson, Scott A and Mitra, Dipankar and Arunachalam, Shivaram P},
  title = {Leveraging Artificial Intelligence for the Diagnosis of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: Opportunities, Challenges, and Future Perspectives},
  journal = {Advances in Respiratory Medicine},
  year = {2025},
  doi = {10.3390/arm93050047}
}
Kostenlos starten →